ici 204,219 has been researched along with pobilukast in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krell, RD; Shaw, A | 1 |
Aharony, D; Hesp, B; Keith, RA; Krell, RD; Maduskuie, TP; Matassa, VG; Shapiro, HS; Snyder, DW | 1 |
Brooks, CD; Summers, JB | 1 |
Ames, RS; Bergsma, DJ; Buckley, PT; Chambers, J; Dytko, GM; Ellis, C; Elshourbagy, N; Foley, JJ; Halsey, W; Hay, DW; Herrity, NC; Jenkins, O; Muccitelli, RM; Muir, AI; Murdock, PR; Nuthulaganti, P; Sarau, HM; Sathe, G; Schmidt, DB; Wilson, S | 1 |
Joos, GF; Kips, JC; Pauwels, RA | 1 |
Conklyn, M; Showell, HJ; Watson, JW | 1 |
Wenzel, SE | 1 |
Aharony, D | 1 |
Ciocca, V; Hay, DW; Leonard, TB; Luttmann, MA; Panettieri, RA; Tan, EM | 1 |
4 review(s) available for ici 204,219 and pobilukast
Article | Year |
---|---|
Peptide leukotrienes: current status of research.
Topics: Acetophenones; Humans; Leukotriene Antagonists; Leukotrienes; Molecular Structure; Peptides; Receptors, Immunologic; Receptors, Leukotriene; Tetrazoles | 1991 |
Modulators of leukotriene biosynthesis and receptor activation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene | 1996 |
New approaches to anti-inflammatory therapy for asthma.
Topics: Anti-Asthmatic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Dicarboxylic Acids; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Steroids; Sulfonamides; Tosyl Compounds | 1998 |
Pharmacology of leukotriene receptor antagonists.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Cyclopropanes; Dicarboxylic Acids; Disease Models, Animal; Humans; In Vitro Techniques; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds | 1998 |
5 other study(ies) available for ici 204,219 and pobilukast
Article | Year |
---|---|
Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.
Topics: Animals; Dyspnea; Guinea Pigs; In Vitro Techniques; Indazoles; Indoles; Muscle Contraction; Pyrazoles; SRS-A; Structure-Activity Relationship | 1990 |
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
Topics: Amino Acid Sequence; Base Sequence; Binding Sites; Biological Transport; Calcium; Cells, Cultured; Cloning, Molecular; Humans; Leukotriene D4; Membrane Proteins; Molecular Sequence Data; Pertussis Toxin; Receptors, Leukotriene; Signal Transduction; Virulence Factors, Bordetella | 1999 |
Bronchodilatory action of cysteinyl-leukotriene receptors.
Topics: Azides; Bronchi; Dicarboxylic Acids; Furans; Humans; Indoles; Phenylcarbamates; SRS-A; Sulfonamides; Tosyl Compounds | 1991 |
IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators.
Topics: Acute Disease; Animals; Azepines; Bronchoconstriction; Dicarboxylic Acids; Dose-Response Relationship, Drug; Furans; Guinea Pigs; Immunization; Immunoglobulin G; Indoles; Lipids; Lung; Male; Ovalbumin; Phenylcarbamates; Piroxicam; Platelet Activating Factor; Propranolol; Pyrilamine; Respiratory Hypersensitivity; SRS-A; Sulfonamides; Tosyl Compounds; Triazoles | 1990 |
Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists.
Topics: Asthma; Carbachol; Cells, Cultured; Chromones; Dicarboxylic Acids; DNA Replication; Epidermal Growth Factor; Extracellular Matrix Proteins; Gene Expression Regulation; Humans; Indoles; Leukotriene Antagonists; Leukotriene D4; Membrane Proteins; Muscle Contraction; Muscle, Smooth, Vascular; Phenylcarbamates; Receptors, Leukotriene; RNA, Messenger; Sulfonamides; Tosyl Compounds; Trachea; Transforming Growth Factor beta | 1998 |